𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome

✍ Scribed by Montillo, Marco; Schinkoethe, Timo; Elter, Thomas

Book ID
118236130
Publisher
Informa plc
Year
2005
Tongue
English
Weight
133 KB
Volume
23
Category
Article
ISSN
0735-7907

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.38 Interest of Early Determination of
5.38 Interest of Early Determination of Bone Marrow Minimal Residual Disease by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: the Experience of the CLL2007FMP, an Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine, Cyclophosphamide, and Rituximab versus Fludarabine, Cyclophosphamide, and MabCampath in Previously Untreated B-Chronic Lymphocytic Leukemia Patients
✍ Remi Letestu; Stephane Leprêtre; Christine Arnoulet; Lucille Baseggio; Lydia Cam 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 81 KB